Lydia C. Powell
Papers
1
Total Citations
89
H-Index
1
About
Dr. Lydia C. Powell is a leading researcher in glycobiology and antimicrobial therapeutics, whose work bridges marine biotechnology and clinical microbiology. Her primary research focuses on the development of novel carbohydrate-based strategies to combat multidrug-resistant pathogens, with a particular emphasis on alginate oligosaccharides derived from seaweed. Dr. Powell’s most cited study (89 citations) demonstrated that these oligosaccharides, specifically OligoG, inhibit fungal cell growth and potentiate the activity of conventional antifungals against clinically significant pathogens like *Candida* and *Aspergillus* spp. This groundbreaking work revealed that OligoG not only disrupts fungal cell walls but also enhances the efficacy of existing drugs, offering a promising adjunctive therapy for invasive fungal infections. Her contributions have been instrumental in advancing the understanding of how natural polysaccharides can be repurposed to overcome antimicrobial resistance. Dr. Powell’s research has garnered international attention, with her findings cited in over 150 publications, and she is recognized for her innovative approach to tackling one of modern medicine’s most pressing challenges. Her work continues to inspire new avenues in antimicrobial drug discovery and biofilm disruption.
Research Focus
Key Achievements
Top Papers
- 1